MedPath

Coronary Physiology Peri-Transcatheter Left-sided Valvular interventions in Patients with Severe Aortic Stenosis or Mitral Regurgitatio

Recruiting
Conditions
coronary artery disease
valvular heart disease
10011082
Registration Number
NL-OMON53992
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
150
Inclusion Criteria

1. Age >= 18.
2. a. TAVI Cohort: severe aortic valve stenosis for which TAVI is scheduled
after discussion in the Heart Team.
b. TVMR Cohort: severe functional mitral regurgitation for which TVMR
is scheduled after discussion in the Heart Team.
3. At least intermediate coronary artery disease, defined as 50 - 99% DS in a
vessel >=2.5 mm.
4. Elective procedure.
5. Written informed consent.

Exclusion Criteria

1. TAVI cohort: height coronary ostia < 10 mm.
2. Severe chronic kindey disease, defined as estimated glomerular filtration
rate < 30 ml/min.
3. Contra-indication for intravenous adenosine (severe asthma or chronic
obstructive pulmonary disease, known allergy to adenosine or precious reported
bronchospasm in response to adenosine).
4. Degenerated surgical or transcatheter aortic valve bioprosthesis.
5. Vessels that have collaterals to a chronic total occlusion or that are
supplied by an arterial or venous bypass graft will not be interrogated in this
study.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The change in the FFR value before and after transcatheter left-sided valvular<br /><br>intervention (i.e. TAVI or TMVR).</p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath